Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Atmar

Showing results (41-50 of 261) with videos related to

Pageof 27
Sort By:
Clinical Therapeutics|July 31, 2017
Prospects and Challenges in the Development of a Norovirus VaccineNicolas W Cortes-Penfield, Sasirekha Ramani, Mary K Estes, et al.
The Journal of Infection|April 23, 2005
Bacteraemia in the elderly: predictors of outcome in an urban teaching hospitalBenjamin M Greenberg, Robert L Atmar, Charles E Stager, et al.
The American Journal of Medicine|May 19, 2021
'String Test' for Hypermucoviscous Klebsiella pneumoniaeElizabeth F Eisenmenger, Emmanuel Guajardo, Natalie Finch, et al.
Research in Microbiology|August 18, 2004
Rotavirus VLP2/6: a new tool for tracking rotavirus in the marine environmentFabienne Loisy, Robert L Atmar, Jean Cohen, et al.
Journal of Medical Virology|July 21, 2005
Norwalk virus infection associates with secretor status genotyped from seraAnne M Hutson, Fabrice Airaud, Jacques LePendu, et al.
Protein Engineering, Design & Selection : PEDS|December 31, 2016
Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirusAmy M Hurwitz, Wanzhi Huang, Mary K Estes, et al.
Vaccines|January 24, 2025
Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in AdultsGeert Leroux-Roels, Robert L Atmar, Jakob P Cramer, et al.
The Journal of Infectious Diseases|April 14, 2021
Topical Imiquimod Does Not Provide an Adjuvant Effect When Administered With Inactivated Influenza A/H5N1 Vaccine in Healthy Young AdultsHana M El Sahly, Robert L Atmar, Eli Sendra, et al.
The Journal of Infectious Diseases|August 30, 2008
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variantsWendy A Keitel, Robert L Atmar, Diane Nino, et al.
The Journal of Clinical Investigation|October 27, 2020
Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrumJill E Weatherhead, Eva Clark, Tiphanie P Vogel, et al.
Pageof 27

Showing results (41-50 of 261) with videos related to

Sort By:
Pageof 27
Clinical Therapeutics|July 31, 2017
Prospects and Challenges in the Development of a Norovirus VaccineNicolas W Cortes-Penfield, Sasirekha Ramani, Mary K Estes, et al.
The Journal of Infection|April 23, 2005
Bacteraemia in the elderly: predictors of outcome in an urban teaching hospitalBenjamin M Greenberg, Robert L Atmar, Charles E Stager, et al.
The American Journal of Medicine|May 19, 2021
'String Test' for Hypermucoviscous Klebsiella pneumoniaeElizabeth F Eisenmenger, Emmanuel Guajardo, Natalie Finch, et al.
Research in Microbiology|August 18, 2004
Rotavirus VLP2/6: a new tool for tracking rotavirus in the marine environmentFabienne Loisy, Robert L Atmar, Jean Cohen, et al.
Journal of Medical Virology|July 21, 2005
Norwalk virus infection associates with secretor status genotyped from seraAnne M Hutson, Fabrice Airaud, Jacques LePendu, et al.
Protein Engineering, Design & Selection : PEDS|December 31, 2016
Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirusAmy M Hurwitz, Wanzhi Huang, Mary K Estes, et al.
Vaccines|January 24, 2025
Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in AdultsGeert Leroux-Roels, Robert L Atmar, Jakob P Cramer, et al.
The Journal of Infectious Diseases|April 14, 2021
Topical Imiquimod Does Not Provide an Adjuvant Effect When Administered With Inactivated Influenza A/H5N1 Vaccine in Healthy Young AdultsHana M El Sahly, Robert L Atmar, Eli Sendra, et al.
The Journal of Infectious Diseases|August 30, 2008
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variantsWendy A Keitel, Robert L Atmar, Diane Nino, et al.
The Journal of Clinical Investigation|October 27, 2020
Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrumJill E Weatherhead, Eva Clark, Tiphanie P Vogel, et al.
Pageof 27